WO1999050244A1 - Agents indicateurs doubles comportant un radical libre nitroxyde - Google Patents
Agents indicateurs doubles comportant un radical libre nitroxyde Download PDFInfo
- Publication number
- WO1999050244A1 WO1999050244A1 PCT/US1999/006688 US9906688W WO9950244A1 WO 1999050244 A1 WO1999050244 A1 WO 1999050244A1 US 9906688 W US9906688 W US 9906688W WO 9950244 A1 WO9950244 A1 WO 9950244A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- nitroxide
- dual
- fluorophore
- fluorescent
- moiety
- Prior art date
Links
- -1 Nitroxide free radical Chemical class 0.000 title claims abstract description 79
- 230000009977 dual effect Effects 0.000 title claims abstract description 58
- 125000006850 spacer group Chemical group 0.000 claims abstract description 29
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical group ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 claims description 78
- 239000000203 mixture Substances 0.000 claims description 76
- 239000000523 sample Substances 0.000 claims description 43
- 150000003254 radicals Chemical class 0.000 claims description 29
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical class C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 14
- 239000012634 fragment Substances 0.000 claims description 13
- 238000010791 quenching Methods 0.000 claims description 13
- 230000000171 quenching effect Effects 0.000 claims description 13
- 230000009467 reduction Effects 0.000 claims description 12
- 230000003993 interaction Effects 0.000 claims description 11
- DZBUGLKDJFMEHC-UHFFFAOYSA-N acridine Chemical compound C1=CC=CC2=CC3=CC=CC=C3N=C21 DZBUGLKDJFMEHC-UHFFFAOYSA-N 0.000 claims description 8
- 125000003118 aryl group Chemical group 0.000 claims description 8
- 125000000623 heterocyclic group Chemical group 0.000 claims description 8
- 230000005292 diamagnetic effect Effects 0.000 claims description 7
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Chemical class COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 7
- 230000009466 transformation Effects 0.000 claims description 5
- 125000003277 amino group Chemical group 0.000 claims description 4
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N coumarin Chemical compound C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 claims description 4
- 125000001295 dansyl group Chemical group [H]C1=C([H])C(N(C([H])([H])[H])C([H])([H])[H])=C2C([H])=C([H])C([H])=C(C2=C1[H])S(*)(=O)=O 0.000 claims description 4
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 claims description 4
- 125000000524 functional group Chemical group 0.000 claims description 4
- DLBFLQKQABVKGT-UHFFFAOYSA-L lucifer yellow dye Chemical compound [Li+].[Li+].[O-]S(=O)(=O)C1=CC(C(N(C(=O)NN)C2=O)=O)=C3C2=CC(S([O-])(=O)=O)=CC3=C1N DLBFLQKQABVKGT-UHFFFAOYSA-L 0.000 claims description 4
- PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 claims description 4
- 239000004215 Carbon black (E152) Substances 0.000 claims description 2
- 125000005842 heteroatom Chemical group 0.000 claims description 2
- 229930195733 hydrocarbon Natural products 0.000 claims description 2
- 150000002430 hydrocarbons Chemical group 0.000 claims description 2
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Chemical class C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 claims 6
- MPLHNVLQVRSVEE-UHFFFAOYSA-N texas red Chemical compound [O-]S(=O)(=O)C1=CC(S(Cl)(=O)=O)=CC=C1C(C1=CC=2CCCN3CCCC(C=23)=C1O1)=C2C1=C(CCC1)C3=[N+]1CCCC3=C2 MPLHNVLQVRSVEE-UHFFFAOYSA-N 0.000 claims 3
- ZCQWOFVYLHDMMC-UHFFFAOYSA-N Oxazole Chemical class C1=COC=N1 ZCQWOFVYLHDMMC-UHFFFAOYSA-N 0.000 claims 2
- 150000003233 pyrroles Chemical class 0.000 claims 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims 1
- 125000004122 cyclic group Chemical group 0.000 claims 1
- 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims 1
- 230000006798 recombination Effects 0.000 claims 1
- 238000005215 recombination Methods 0.000 claims 1
- 125000000547 substituted alkyl group Chemical group 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 abstract description 26
- 239000000126 substance Substances 0.000 abstract description 8
- 239000003550 marker Substances 0.000 abstract 1
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 101
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 57
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 55
- 239000007787 solid Substances 0.000 description 51
- 230000015572 biosynthetic process Effects 0.000 description 49
- 239000003480 eluent Substances 0.000 description 46
- 238000003786 synthesis reaction Methods 0.000 description 41
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 39
- 239000000243 solution Substances 0.000 description 38
- 238000000034 method Methods 0.000 description 37
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 36
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 32
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 30
- 238000004809 thin layer chromatography Methods 0.000 description 29
- 239000011541 reaction mixture Substances 0.000 description 26
- 150000001875 compounds Chemical class 0.000 description 23
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 22
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 22
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 21
- 238000006243 chemical reaction Methods 0.000 description 21
- 239000000741 silica gel Substances 0.000 description 21
- 229910002027 silica gel Inorganic materials 0.000 description 21
- 238000004435 EPR spectroscopy Methods 0.000 description 20
- 229940093499 ethyl acetate Drugs 0.000 description 19
- 235000019439 ethyl acetate Nutrition 0.000 description 19
- 238000007254 oxidation reaction Methods 0.000 description 18
- 230000003647 oxidation Effects 0.000 description 17
- 238000003756 stirring Methods 0.000 description 17
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 16
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 16
- 239000002253 acid Substances 0.000 description 16
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 15
- 229910052786 argon Inorganic materials 0.000 description 15
- 238000002360 preparation method Methods 0.000 description 15
- 239000000706 filtrate Substances 0.000 description 14
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 13
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 12
- 239000000543 intermediate Substances 0.000 description 12
- 238000002372 labelling Methods 0.000 description 12
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 11
- 235000019341 magnesium sulphate Nutrition 0.000 description 11
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 10
- 238000001727 in vivo Methods 0.000 description 10
- 230000035945 sensitivity Effects 0.000 description 10
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 9
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 9
- 150000001408 amides Chemical class 0.000 description 9
- 239000007850 fluorescent dye Substances 0.000 description 9
- 239000000047 product Substances 0.000 description 9
- 238000011160 research Methods 0.000 description 9
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 8
- 239000003054 catalyst Substances 0.000 description 8
- 239000000284 extract Substances 0.000 description 8
- 238000010348 incorporation Methods 0.000 description 8
- NUJOXMJBOLGQSY-UHFFFAOYSA-N manganese dioxide Chemical compound O=[Mn]=O NUJOXMJBOLGQSY-UHFFFAOYSA-N 0.000 description 8
- 238000000746 purification Methods 0.000 description 8
- 239000000725 suspension Substances 0.000 description 8
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 7
- JWUXJYZVKZKLTJ-UHFFFAOYSA-N Triacetonamine Chemical compound CC1(C)CC(=O)CC(C)(C)N1 JWUXJYZVKZKLTJ-UHFFFAOYSA-N 0.000 description 7
- 150000001412 amines Chemical class 0.000 description 7
- 238000011161 development Methods 0.000 description 7
- 230000018109 developmental process Effects 0.000 description 7
- 238000005259 measurement Methods 0.000 description 7
- 230000007246 mechanism Effects 0.000 description 7
- 230000005298 paramagnetic effect Effects 0.000 description 7
- BBEAQIROQSPTKN-UHFFFAOYSA-N pyrene Chemical compound C1=CC=C2C=CC3=CC=CC4=CC=C1C2=C43 BBEAQIROQSPTKN-UHFFFAOYSA-N 0.000 description 7
- 230000002829 reductive effect Effects 0.000 description 7
- 239000007858 starting material Substances 0.000 description 7
- YZVWKHVRBDQPMQ-UHFFFAOYSA-N 1-aminopyrene Chemical compound C1=C2C(N)=CC=C(C=C3)C2=C2C3=CC=CC2=C1 YZVWKHVRBDQPMQ-UHFFFAOYSA-N 0.000 description 6
- MDIDPQFUUCZBDH-UHFFFAOYSA-N 3-oxido-2,5-dihydro-1H-imidazol-3-ium-4-carboxylic acid Chemical compound OC(=O)C1=[N+]([O-])CNC1 MDIDPQFUUCZBDH-UHFFFAOYSA-N 0.000 description 6
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 6
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 6
- 238000005917 acylation reaction Methods 0.000 description 6
- 150000008064 anhydrides Chemical class 0.000 description 6
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 6
- 229910052794 bromium Inorganic materials 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 6
- 239000013078 crystal Substances 0.000 description 6
- NMHMNPHRMNGLLB-UHFFFAOYSA-N phloretic acid Chemical compound OC(=O)CCC1=CC=C(O)C=C1 NMHMNPHRMNGLLB-UHFFFAOYSA-N 0.000 description 6
- 230000008569 process Effects 0.000 description 6
- 150000003839 salts Chemical class 0.000 description 6
- 238000004611 spectroscopical analysis Methods 0.000 description 6
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 5
- NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical compound ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 description 5
- 230000010933 acylation Effects 0.000 description 5
- AMEDKBHURXXSQO-UHFFFAOYSA-N azonous acid Chemical compound ONO AMEDKBHURXXSQO-UHFFFAOYSA-N 0.000 description 5
- 239000003153 chemical reaction reagent Substances 0.000 description 5
- 238000001914 filtration Methods 0.000 description 5
- 238000003760 magnetic stirring Methods 0.000 description 5
- 239000012528 membrane Substances 0.000 description 5
- 239000001301 oxygen Substances 0.000 description 5
- 229910052760 oxygen Inorganic materials 0.000 description 5
- DTQVDTLACAAQTR-UHFFFAOYSA-N trifluoroacetic acid Substances OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 5
- NMPVEAUIHMEAQP-UHFFFAOYSA-N 2-Bromoacetaldehyde Chemical compound BrCC=O NMPVEAUIHMEAQP-UHFFFAOYSA-N 0.000 description 4
- RKZIPFOHRUCGGS-UHFFFAOYSA-N 4,5-dihydroimidazole-1-carboxylic acid Chemical compound OC(=O)N1CCN=C1 RKZIPFOHRUCGGS-UHFFFAOYSA-N 0.000 description 4
- XPDXVDYUQZHFPV-UHFFFAOYSA-N Dansyl Chloride Chemical compound C1=CC=C2C(N(C)C)=CC=CC2=C1S(Cl)(=O)=O XPDXVDYUQZHFPV-UHFFFAOYSA-N 0.000 description 4
- 150000001299 aldehydes Chemical class 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 238000013459 approach Methods 0.000 description 4
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 4
- 239000012043 crude product Substances 0.000 description 4
- 150000004985 diamines Chemical class 0.000 description 4
- 238000003818 flash chromatography Methods 0.000 description 4
- GVEPBJHOBDJJJI-UHFFFAOYSA-N fluoranthrene Natural products C1=CC(C2=CC=CC=C22)=C3C2=CC=CC3=C1 GVEPBJHOBDJJJI-UHFFFAOYSA-N 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- 230000007062 hydrolysis Effects 0.000 description 4
- 238000006460 hydrolysis reaction Methods 0.000 description 4
- 229910010272 inorganic material Inorganic materials 0.000 description 4
- 239000011147 inorganic material Substances 0.000 description 4
- 238000002955 isolation Methods 0.000 description 4
- 230000005291 magnetic effect Effects 0.000 description 4
- 239000003068 molecular probe Substances 0.000 description 4
- 239000002244 precipitate Substances 0.000 description 4
- RGNMXKKNDSHTFD-UHFFFAOYSA-N pyren-1-ylmethylazanium;chloride Chemical compound Cl.C1=C2C(CN)=CC=C(C=C3)C2=C2C3=CC=CC2=C1 RGNMXKKNDSHTFD-UHFFFAOYSA-N 0.000 description 4
- 238000010992 reflux Methods 0.000 description 4
- 159000000000 sodium salts Chemical class 0.000 description 4
- 239000012258 stirred mixture Substances 0.000 description 4
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 4
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 4
- JQUCWIWWWKZNCS-LESHARBVSA-N C(C1=CC=CC=C1)(=O)NC=1SC[C@H]2[C@@](N1)(CO[C@H](C2)C)C=2SC=C(N2)NC(=O)C2=NC=C(C=C2)OC(F)F Chemical compound C(C1=CC=CC=C1)(=O)NC=1SC[C@H]2[C@@](N1)(CO[C@H](C2)C)C=2SC=C(N2)NC(=O)C2=NC=C(C=C2)OC(F)F JQUCWIWWWKZNCS-LESHARBVSA-N 0.000 description 3
- 0 CC(C)(C(C)(C)II=C1*)N1O Chemical compound CC(C)(C(C)(C)II=C1*)N1O 0.000 description 3
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 3
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 3
- 239000005977 Ethylene Substances 0.000 description 3
- BAPJBEWLBFYGME-UHFFFAOYSA-N Methyl acrylate Chemical compound COC(=O)C=C BAPJBEWLBFYGME-UHFFFAOYSA-N 0.000 description 3
- PCLIMKBDDGJMGD-UHFFFAOYSA-N N-bromosuccinimide Chemical compound BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 description 3
- 238000005481 NMR spectroscopy Methods 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical class [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 3
- GPWHDDKQSYOYBF-UHFFFAOYSA-N ac1l2u0q Chemical compound Br[Br-]Br GPWHDDKQSYOYBF-UHFFFAOYSA-N 0.000 description 3
- 229960000583 acetic acid Drugs 0.000 description 3
- 150000001263 acyl chlorides Chemical class 0.000 description 3
- 150000001409 amidines Chemical class 0.000 description 3
- 238000009833 condensation Methods 0.000 description 3
- 230000005494 condensation Effects 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- ZFKJVJIDPQDDFY-UHFFFAOYSA-N fluorescamine Chemical compound C12=CC=CC=C2C(=O)OC1(C1=O)OC=C1C1=CC=CC=C1 ZFKJVJIDPQDDFY-UHFFFAOYSA-N 0.000 description 3
- 150000002443 hydroxylamines Chemical class 0.000 description 3
- 150000002466 imines Chemical class 0.000 description 3
- 239000012535 impurity Substances 0.000 description 3
- 230000003834 intracellular effect Effects 0.000 description 3
- 230000033001 locomotion Effects 0.000 description 3
- 238000012544 monitoring process Methods 0.000 description 3
- 239000012038 nucleophile Substances 0.000 description 3
- 125000002524 organometallic group Chemical group 0.000 description 3
- 230000005408 paramagnetism Effects 0.000 description 3
- DGTNSSLYPYDJGL-UHFFFAOYSA-N phenyl isocyanate Chemical compound O=C=NC1=CC=CC=C1 DGTNSSLYPYDJGL-UHFFFAOYSA-N 0.000 description 3
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 3
- TZNXEWGKCWPLQI-UHFFFAOYSA-N pyren-1-ylmethanamine Chemical class C1=C2C(CN)=CC=C(C=C3)C2=C2C3=CC=CC2=C1 TZNXEWGKCWPLQI-UHFFFAOYSA-N 0.000 description 3
- MFUFBSLEAGDECJ-UHFFFAOYSA-N pyren-2-ylamine Natural products C1=CC=C2C=CC3=CC(N)=CC4=CC=C1C2=C43 MFUFBSLEAGDECJ-UHFFFAOYSA-N 0.000 description 3
- 238000006467 substitution reaction Methods 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- GEYOCULIXLDCMW-UHFFFAOYSA-N 1,2-phenylenediamine Chemical compound NC1=CC=CC=C1N GEYOCULIXLDCMW-UHFFFAOYSA-N 0.000 description 2
- KKHFRAFPESRGGD-UHFFFAOYSA-N 1,3-dimethyl-7-[3-(n-methylanilino)propyl]purine-2,6-dione Chemical compound C1=NC=2N(C)C(=O)N(C)C(=O)C=2N1CCCN(C)C1=CC=CC=C1 KKHFRAFPESRGGD-UHFFFAOYSA-N 0.000 description 2
- CBCKQZAAMUWICA-UHFFFAOYSA-N 1,4-phenylenediamine Chemical compound NC1=CC=C(N)C=C1 CBCKQZAAMUWICA-UHFFFAOYSA-N 0.000 description 2
- GMIPCEOKROIPSM-UHFFFAOYSA-N 2,2,4,5,5-pentamethyl-3-oxido-1h-imidazol-3-ium Chemical compound CC1=[N+]([O-])C(C)(C)NC1(C)C GMIPCEOKROIPSM-UHFFFAOYSA-N 0.000 description 2
- POAGFQOGFRYOFM-UHFFFAOYSA-N 2,2,5,5-tetramethylpyrrolidine-3-carboxamide Chemical compound CC1(C)CC(C(N)=O)C(C)(C)N1 POAGFQOGFRYOFM-UHFFFAOYSA-N 0.000 description 2
- WGFNXGPBPIJYLI-UHFFFAOYSA-N 2,6-difluoro-3-[(3-fluorophenyl)sulfonylamino]-n-(3-methoxy-1h-pyrazolo[3,4-b]pyridin-5-yl)benzamide Chemical compound C1=C2C(OC)=NNC2=NC=C1NC(=O)C(C=1F)=C(F)C=CC=1NS(=O)(=O)C1=CC=CC(F)=C1 WGFNXGPBPIJYLI-UHFFFAOYSA-N 0.000 description 2
- FGLBSLMDCBOPQK-UHFFFAOYSA-N 2-nitropropane Chemical compound CC(C)[N+]([O-])=O FGLBSLMDCBOPQK-UHFFFAOYSA-N 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 2
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- BQXUPNKLZNSUMC-YUQWMIPFSA-N CCN(CCCCCOCC(=O)N[C@H](C(=O)N1C[C@H](O)C[C@H]1C(=O)N[C@@H](C)c1ccc(cc1)-c1scnc1C)C(C)(C)C)CCOc1ccc(cc1)C(=O)c1c(sc2cc(O)ccc12)-c1ccc(O)cc1 Chemical compound CCN(CCCCCOCC(=O)N[C@H](C(=O)N1C[C@H](O)C[C@H]1C(=O)N[C@@H](C)c1ccc(cc1)-c1scnc1C)C(C)(C)C)CCOc1ccc(cc1)C(=O)c1c(sc2cc(O)ccc12)-c1ccc(O)cc1 BQXUPNKLZNSUMC-YUQWMIPFSA-N 0.000 description 2
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 2
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 2
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 2
- ZRALSGWEFCBTJO-UHFFFAOYSA-N Guanidine Chemical compound NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 description 2
- 206010020843 Hyperthermia Diseases 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- AJRQIXBBIDPNGK-BVSLBCMMSA-N benzyl n-[(2s)-1-[[(2s)-1-(1,3-benzothiazol-2-yl)-1-oxo-3-[(3s)-2-oxopyrrolidin-3-yl]propan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]carbamate Chemical compound N([C@@H](CC(C)C)C(=O)N[C@@H](C[C@H]1C(NCC1)=O)C(=O)C=1SC2=CC=CC=C2N=1)C(=O)OCC1=CC=CC=C1 AJRQIXBBIDPNGK-BVSLBCMMSA-N 0.000 description 2
- 230000031709 bromination Effects 0.000 description 2
- 238000005893 bromination reaction Methods 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- 239000003638 chemical reducing agent Substances 0.000 description 2
- WDECIBYCCFPHNR-UHFFFAOYSA-N chrysene Chemical compound C1=CC=CC2=CC=C3C4=CC=CC=C4C=CC3=C21 WDECIBYCCFPHNR-UHFFFAOYSA-N 0.000 description 2
- OPQARKPSCNTWTJ-UHFFFAOYSA-L copper(ii) acetate Chemical compound [Cu+2].CC([O-])=O.CC([O-])=O OPQARKPSCNTWTJ-UHFFFAOYSA-L 0.000 description 2
- 238000006352 cycloaddition reaction Methods 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 238000001983 electron spin resonance imaging Methods 0.000 description 2
- 238000001362 electron spin resonance spectrum Methods 0.000 description 2
- RIFGWPKJUGCATF-UHFFFAOYSA-N ethyl chloroformate Chemical compound CCOC(Cl)=O RIFGWPKJUGCATF-UHFFFAOYSA-N 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000012362 glacial acetic acid Substances 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 230000036031 hyperthermia Effects 0.000 description 2
- 239000005457 ice water Substances 0.000 description 2
- 238000011065 in-situ storage Methods 0.000 description 2
- CTAPFRYPJLPFDF-UHFFFAOYSA-N isoxazole Chemical compound C=1C=NOC=1 CTAPFRYPJLPFDF-UHFFFAOYSA-N 0.000 description 2
- 229920002521 macromolecule Polymers 0.000 description 2
- 238000002595 magnetic resonance imaging Methods 0.000 description 2
- 150000004702 methyl esters Chemical class 0.000 description 2
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- CSJXLKVNKAXFSI-UHFFFAOYSA-N n-(2-aminoethyl)-5-(dimethylamino)naphthalene-1-sulfonamide Chemical compound C1=CC=C2C(N(C)C)=CC=CC2=C1S(=O)(=O)NCCN CSJXLKVNKAXFSI-UHFFFAOYSA-N 0.000 description 2
- SQDFHQJTAWCFIB-UHFFFAOYSA-N n-methylidenehydroxylamine Chemical group ON=C SQDFHQJTAWCFIB-UHFFFAOYSA-N 0.000 description 2
- 238000010534 nucleophilic substitution reaction Methods 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 230000001590 oxidative effect Effects 0.000 description 2
- 230000037361 pathway Effects 0.000 description 2
- 239000003208 petroleum Substances 0.000 description 2
- QECIGCMPORCORE-UHFFFAOYSA-N phenanthrene-9-carbaldehyde Chemical compound C1=CC=C2C(C=O)=CC3=CC=CC=C3C2=C1 QECIGCMPORCORE-UHFFFAOYSA-N 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- ZVJHJDDKYZXRJI-UHFFFAOYSA-N pyrroline Natural products C1CC=NC1 ZVJHJDDKYZXRJI-UHFFFAOYSA-N 0.000 description 2
- 230000009257 reactivity Effects 0.000 description 2
- 230000027756 respiratory electron transport chain Effects 0.000 description 2
- JVBXVOWTABLYPX-UHFFFAOYSA-L sodium dithionite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])=O JVBXVOWTABLYPX-UHFFFAOYSA-L 0.000 description 2
- 230000003595 spectral effect Effects 0.000 description 2
- 125000001424 substituent group Chemical group 0.000 description 2
- KZNICNPSHKQLFF-UHFFFAOYSA-N succinimide Chemical compound O=C1CCC(=O)N1 KZNICNPSHKQLFF-UHFFFAOYSA-N 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- LAJAFFLJAJMYLK-CVOKMOJFSA-N (1s,2s,3r,4r)-3-[[5-chloro-2-[[(7s)-4-methoxy-7-morpholin-4-yl-6,7,8,9-tetrahydro-5h-benzo[7]annulen-3-yl]amino]pyrimidin-4-yl]amino]bicyclo[2.2.1]hept-5-ene-2-carboxamide Chemical compound N1([C@H]2CCC3=CC=C(C(=C3CC2)OC)NC=2N=C(C(=CN=2)Cl)N[C@H]2[C@H]([C@@]3([H])C[C@@]2(C=C3)[H])C(N)=O)CCOCC1 LAJAFFLJAJMYLK-CVOKMOJFSA-N 0.000 description 1
- GHYOCDFICYLMRF-UTIIJYGPSA-N (2S,3R)-N-[(2S)-3-(cyclopenten-1-yl)-1-[(2R)-2-methyloxiran-2-yl]-1-oxopropan-2-yl]-3-hydroxy-3-(4-methoxyphenyl)-2-[[(2S)-2-[(2-morpholin-4-ylacetyl)amino]propanoyl]amino]propanamide Chemical compound C1(=CCCC1)C[C@@H](C(=O)[C@@]1(OC1)C)NC([C@H]([C@@H](C1=CC=C(C=C1)OC)O)NC([C@H](C)NC(CN1CCOCC1)=O)=O)=O GHYOCDFICYLMRF-UTIIJYGPSA-N 0.000 description 1
- POPVUKGJWNLYGW-UHFFFAOYSA-N (hydroxyamino) hydrogen sulfate Chemical compound ONOS(O)(=O)=O POPVUKGJWNLYGW-UHFFFAOYSA-N 0.000 description 1
- ADFXKUOMJKEIND-UHFFFAOYSA-N 1,3-dicyclohexylurea Chemical compound C1CCCCC1NC(=O)NC1CCCCC1 ADFXKUOMJKEIND-UHFFFAOYSA-N 0.000 description 1
- JLLNQGHQFQJAKQ-UHFFFAOYSA-N 1,3-dihydroxyimidazolidine Chemical compound ON1CCN(O)C1 JLLNQGHQFQJAKQ-UHFFFAOYSA-N 0.000 description 1
- KQZLRWGGWXJPOS-NLFPWZOASA-N 1-[(1R)-1-(2,4-dichlorophenyl)ethyl]-6-[(4S,5R)-4-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]-5-methylcyclohexen-1-yl]pyrazolo[3,4-b]pyrazine-3-carbonitrile Chemical compound ClC1=C(C=CC(=C1)Cl)[C@@H](C)N1N=C(C=2C1=NC(=CN=2)C1=CC[C@@H]([C@@H](C1)C)N1[C@@H](CCC1)CO)C#N KQZLRWGGWXJPOS-NLFPWZOASA-N 0.000 description 1
- SMZFUMFLNCWTFX-UHFFFAOYSA-N 1-methylidene-2H-pyrene Chemical group C=C1CC=C2C=CC3=CC=CC4=CC=C1C2=C34 SMZFUMFLNCWTFX-UHFFFAOYSA-N 0.000 description 1
- HFPWDSFSCLYXAZ-UHFFFAOYSA-N 2,3-dinitrobutane Chemical compound [O-][N+](=O)C(C)C(C)[N+]([O-])=O HFPWDSFSCLYXAZ-UHFFFAOYSA-N 0.000 description 1
- FFMBYMANYCDCMK-UHFFFAOYSA-N 2,5-dihydro-1h-imidazole Chemical class C1NCN=C1 FFMBYMANYCDCMK-UHFFFAOYSA-N 0.000 description 1
- FQMZXMVHHKXGTM-UHFFFAOYSA-N 2-(1-adamantyl)-n-[2-[2-(2-hydroxyethylamino)ethylamino]quinolin-5-yl]acetamide Chemical compound C1C(C2)CC(C3)CC2CC13CC(=O)NC1=CC=CC2=NC(NCCNCCO)=CC=C21 FQMZXMVHHKXGTM-UHFFFAOYSA-N 0.000 description 1
- VVCMGAUPZIKYTH-VGHSCWAPSA-N 2-acetyloxybenzoic acid;[(2s,3r)-4-(dimethylamino)-3-methyl-1,2-diphenylbutan-2-yl] propanoate;1,3,7-trimethylpurine-2,6-dione Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O.CN1C(=O)N(C)C(=O)C2=C1N=CN2C.C([C@](OC(=O)CC)([C@H](C)CN(C)C)C=1C=CC=CC=1)C1=CC=CC=C1 VVCMGAUPZIKYTH-VGHSCWAPSA-N 0.000 description 1
- LUQZKEZPFQRRRK-UHFFFAOYSA-N 2-methyl-2-nitrosopropane Chemical compound CC(C)(C)N=O LUQZKEZPFQRRRK-UHFFFAOYSA-N 0.000 description 1
- RSEBUVRVKCANEP-UHFFFAOYSA-N 2-pyrroline Chemical compound C1CC=CN1 RSEBUVRVKCANEP-UHFFFAOYSA-N 0.000 description 1
- VMHVSXXACDJVRL-UHFFFAOYSA-N 3,5-dibromo-2,2,6,6-tetramethylpiperidin-4-one;hydron;bromide Chemical compound Br.CC1(C)NC(C)(C)C(Br)C(=O)C1Br VMHVSXXACDJVRL-UHFFFAOYSA-N 0.000 description 1
- RONDWVQEMLDFKA-UHFFFAOYSA-N 3-hydroxy-1-oxido-2,4-dihydroimidazol-1-ium Chemical compound ON1CC=[N+]([O-])C1 RONDWVQEMLDFKA-UHFFFAOYSA-N 0.000 description 1
- XUXUHDYTLNCYQQ-UHFFFAOYSA-N 4-amino-TEMPO Chemical group CC1(C)CC(N)CC(C)(C)N1[O] XUXUHDYTLNCYQQ-UHFFFAOYSA-N 0.000 description 1
- XVMSFILGAMDHEY-UHFFFAOYSA-N 6-(4-aminophenyl)sulfonylpyridin-3-amine Chemical compound C1=CC(N)=CC=C1S(=O)(=O)C1=CC=C(N)C=N1 XVMSFILGAMDHEY-UHFFFAOYSA-N 0.000 description 1
- 241000252095 Congridae Species 0.000 description 1
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical class [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 1
- 239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 238000006736 Huisgen cycloaddition reaction Methods 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- CHJJGSNFBQVOTG-UHFFFAOYSA-N N-methyl-guanidine Natural products CNC(N)=N CHJJGSNFBQVOTG-UHFFFAOYSA-N 0.000 description 1
- 150000001204 N-oxides Chemical class 0.000 description 1
- QOVYHDHLFPKQQG-NDEPHWFRSA-N N[C@@H](CCC(=O)N1CCC(CC1)NC1=C2C=CC=CC2=NC(NCC2=CN(CCCNCCCNC3CCCCC3)N=N2)=N1)C(O)=O Chemical compound N[C@@H](CCC(=O)N1CCC(CC1)NC1=C2C=CC=CC2=NC(NCC2=CN(CCCNCCCNC3CCCCC3)N=N2)=N1)C(O)=O QOVYHDHLFPKQQG-NDEPHWFRSA-N 0.000 description 1
- 229910006080 SO2X Inorganic materials 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- LNUFLCYMSVYYNW-ZPJMAFJPSA-N [(2r,3r,4s,5r,6r)-2-[(2r,3r,4s,5r,6r)-6-[(2r,3r,4s,5r,6r)-6-[(2r,3r,4s,5r,6r)-6-[[(3s,5s,8r,9s,10s,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-3-yl]oxy]-4,5-disulfo Chemical compound O([C@@H]1[C@@H](COS(O)(=O)=O)O[C@@H]([C@@H]([C@H]1OS(O)(=O)=O)OS(O)(=O)=O)O[C@@H]1[C@@H](COS(O)(=O)=O)O[C@@H]([C@@H]([C@H]1OS(O)(=O)=O)OS(O)(=O)=O)O[C@@H]1[C@@H](COS(O)(=O)=O)O[C@H]([C@@H]([C@H]1OS(O)(=O)=O)OS(O)(=O)=O)O[C@@H]1C[C@@H]2CC[C@H]3[C@@H]4CC[C@@H]([C@]4(CC[C@@H]3[C@@]2(C)CC1)C)[C@H](C)CCCC(C)C)[C@H]1O[C@H](COS(O)(=O)=O)[C@@H](OS(O)(=O)=O)[C@H](OS(O)(=O)=O)[C@H]1OS(O)(=O)=O LNUFLCYMSVYYNW-ZPJMAFJPSA-N 0.000 description 1
- PSLUFJFHTBIXMW-WYEYVKMPSA-N [(3r,4ar,5s,6s,6as,10s,10ar,10bs)-3-ethenyl-10,10b-dihydroxy-3,4a,7,7,10a-pentamethyl-1-oxo-6-(2-pyridin-2-ylethylcarbamoyloxy)-5,6,6a,8,9,10-hexahydro-2h-benzo[f]chromen-5-yl] acetate Chemical compound O([C@@H]1[C@@H]([C@]2(O[C@](C)(CC(=O)[C@]2(O)[C@@]2(C)[C@@H](O)CCC(C)(C)[C@@H]21)C=C)C)OC(=O)C)C(=O)NCCC1=CC=CC=N1 PSLUFJFHTBIXMW-WYEYVKMPSA-N 0.000 description 1
- 230000004308 accommodation Effects 0.000 description 1
- PBCJIPOGFJYBJE-UHFFFAOYSA-N acetonitrile;hydrate Chemical compound O.CC#N PBCJIPOGFJYBJE-UHFFFAOYSA-N 0.000 description 1
- 239000003929 acidic solution Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- DQPBABKTKYNPMH-UHFFFAOYSA-N amino hydrogen sulfate Chemical compound NOS(O)(=O)=O DQPBABKTKYNPMH-UHFFFAOYSA-N 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 239000000908 ammonium hydroxide Substances 0.000 description 1
- 239000012491 analyte Substances 0.000 description 1
- 239000012300 argon atmosphere Substances 0.000 description 1
- 150000003934 aromatic aldehydes Chemical class 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- QMMFTRJQCCVPCE-UHFFFAOYSA-N benzyl n-(2-aminoethyl)carbamate Chemical compound NCCNC(=O)OCC1=CC=CC=C1 QMMFTRJQCCVPCE-UHFFFAOYSA-N 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000009141 biological interaction Effects 0.000 description 1
- 230000031018 biological processes and functions Effects 0.000 description 1
- 125000001246 bromo group Chemical class Br* 0.000 description 1
- 125000005997 bromomethyl group Chemical group 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 239000002026 chloroform extract Substances 0.000 description 1
- OQNGCCWBHLEQFN-UHFFFAOYSA-N chloroform;hexane Chemical compound ClC(Cl)Cl.CCCCCC OQNGCCWBHLEQFN-UHFFFAOYSA-N 0.000 description 1
- WORJEOGGNQDSOE-UHFFFAOYSA-N chloroform;methanol Chemical compound OC.ClC(Cl)Cl WORJEOGGNQDSOE-UHFFFAOYSA-N 0.000 description 1
- 238000010549 co-Evaporation Methods 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 229940125797 compound 12 Drugs 0.000 description 1
- 229940125877 compound 31 Drugs 0.000 description 1
- 239000007859 condensation product Substances 0.000 description 1
- 229940039231 contrast media Drugs 0.000 description 1
- 239000002872 contrast media Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000013058 crude material Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 238000010511 deprotection reaction Methods 0.000 description 1
- 229910003460 diamond Inorganic materials 0.000 description 1
- 239000010432 diamond Substances 0.000 description 1
- 125000000950 dibromo group Chemical group Br* 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- IJKVHSBPTUYDLN-UHFFFAOYSA-N dihydroxy(oxo)silane Chemical compound O[Si](O)=O IJKVHSBPTUYDLN-UHFFFAOYSA-N 0.000 description 1
- SWSQBOPZIKWTGO-UHFFFAOYSA-N dimethylaminoamidine Natural products CN(C)C(N)=N SWSQBOPZIKWTGO-UHFFFAOYSA-N 0.000 description 1
- 229910001882 dioxygen Inorganic materials 0.000 description 1
- 235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 description 1
- DWCLXOREGBLXTD-UHFFFAOYSA-N dmdnb Chemical compound [O-][N+](=O)C(C)(C)C(C)(C)[N+]([O-])=O DWCLXOREGBLXTD-UHFFFAOYSA-N 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000007247 enzymatic mechanism Effects 0.000 description 1
- ZKQFHRVKCYFVCN-UHFFFAOYSA-N ethoxyethane;hexane Chemical compound CCOCC.CCCCCC ZKQFHRVKCYFVCN-UHFFFAOYSA-N 0.000 description 1
- 125000004494 ethyl ester group Chemical group 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 230000005281 excited state Effects 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 238000001506 fluorescence spectroscopy Methods 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 125000001072 heteroaryl group Chemical group 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 125000004356 hydroxy functional group Chemical group O* 0.000 description 1
- 125000002349 hydroxyamino group Chemical group [H]ON([H])[*] 0.000 description 1
- TUJKJAMUKRIRHC-UHFFFAOYSA-N hydroxyl Chemical compound [OH] TUJKJAMUKRIRHC-UHFFFAOYSA-N 0.000 description 1
- 125000001841 imino group Chemical group [H]N=* 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 230000000155 isotopic effect Effects 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 230000037353 metabolic pathway Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- HZVOZRGWRWCICA-UHFFFAOYSA-N methanediyl Chemical class [CH2] HZVOZRGWRWCICA-UHFFFAOYSA-N 0.000 description 1
- 238000000386 microscopy Methods 0.000 description 1
- 239000004005 microsphere Substances 0.000 description 1
- FTYQYJPGDGCGEH-UHFFFAOYSA-N n-(3-aminopropyl)-5-(dimethylamino)naphthalene-1-sulfonamide Chemical compound C1=CC=C2C(N(C)C)=CC=CC2=C1S(=O)(=O)NCCCN FTYQYJPGDGCGEH-UHFFFAOYSA-N 0.000 description 1
- IUVKJBVHRBBGOL-UHFFFAOYSA-N n-[3-(hydroxyamino)-2,3-dimethylbutan-2-yl]hydroxylamine;sulfuric acid Chemical compound OS(O)(=O)=O.ONC(C)(C)C(C)(C)NO IUVKJBVHRBBGOL-UHFFFAOYSA-N 0.000 description 1
- SZTLZVPTFVVGML-UHFFFAOYSA-N n-ethenylidenehydroxylamine Chemical group ON=C=C SZTLZVPTFVVGML-UHFFFAOYSA-N 0.000 description 1
- 150000005209 naphthoic acids Chemical class 0.000 description 1
- 150000002825 nitriles Chemical class 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 150000002832 nitroso derivatives Chemical class 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 238000005935 nucleophilic addition reaction Methods 0.000 description 1
- 238000005580 one pot reaction Methods 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- DTHHUAXKOMWYBI-UHFFFAOYSA-N oxadiazolidine Chemical compound C1CONN1 DTHHUAXKOMWYBI-UHFFFAOYSA-N 0.000 description 1
- 230000033116 oxidation-reduction process Effects 0.000 description 1
- 238000002496 oximetry Methods 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- ORQYPOUSZINNCB-UHFFFAOYSA-N potassium;hypobromite Chemical compound [K+].Br[O-] ORQYPOUSZINNCB-UHFFFAOYSA-N 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000000039 preparative column chromatography Methods 0.000 description 1
- 238000012746 preparative thin layer chromatography Methods 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 230000005588 protonation Effects 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 238000003077 quantum chemistry computational method Methods 0.000 description 1
- 238000006862 quantum yield reaction Methods 0.000 description 1
- 238000010526 radical polymerization reaction Methods 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 238000006479 redox reaction Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- XMVONEAAOPAGAO-UHFFFAOYSA-N sodium tungstate Chemical compound [Na+].[Na+].[O-][W]([O-])(=O)=O XMVONEAAOPAGAO-UHFFFAOYSA-N 0.000 description 1
- CRWJEUDFKNYSBX-UHFFFAOYSA-N sodium;hypobromite Chemical compound [Na+].Br[O-] CRWJEUDFKNYSBX-UHFFFAOYSA-N 0.000 description 1
- 239000011343 solid material Substances 0.000 description 1
- 239000012265 solid product Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 210000001768 subcellular fraction Anatomy 0.000 description 1
- 229960002317 succinimide Drugs 0.000 description 1
- 230000006103 sulfonylation Effects 0.000 description 1
- 238000005694 sulfonylation reaction Methods 0.000 description 1
- RTXHCGMQVKSQQC-UHFFFAOYSA-N tert-butyl 2,4-diaminobutanoate Chemical compound CC(C)(C)OC(=O)C(N)CCN RTXHCGMQVKSQQC-UHFFFAOYSA-N 0.000 description 1
- YBRBMKDOPFTVDT-UHFFFAOYSA-N tert-butylamine Chemical compound CC(C)(C)N YBRBMKDOPFTVDT-UHFFFAOYSA-N 0.000 description 1
- 125000003396 thiol group Chemical group [H]S* 0.000 description 1
- 230000036962 time dependent Effects 0.000 description 1
- ILWRPSCZWQJDMK-UHFFFAOYSA-N triethylazanium;chloride Chemical compound Cl.CCN(CC)CC ILWRPSCZWQJDMK-UHFFFAOYSA-N 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/88—Nitrogen atoms, e.g. allantoin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Definitions
- the present invention relates generally to the fields of novel molecular probes and labels that combine the features of fluorescent probes with the paramagnetism of spin probes. They can be recognized by means of both fluorescent spectroscopy and electron paramagenetic (or spin) resonance (EPR on ESR) spectroscopy as well.
- the invention also relates to the fields of immunodiagnostics, protein and membrane analysis, spin oximetry, and studies of intracellular pH and surface potentials of cells, as the novel probes and labels may be used to render measurements by fluorescent spectroscopy and/or EPR.
- Nitroxides are examples of stable organic free radicals (Berliner, L J., Spin Labeling. Theory and Applications. Vol. 1 and 2, Academic Press, New York, 1976, 1979). These N,N-disubstituted >NO radicals are stable enough to be prepared, handled and stored like conventional organic compounds (Keana, J.F. W., Chem. Rev., 78:37, 1978). They possess an open electron shell (an unpaired electron), and, like all free radicals, display paramagnetic properties. This characteristic allows their use as reporter molecules, recognizable by Electron Paramagnetic (or Spin) Resonance (EPR or ESR) spectroscopy (Keana, J.F.W., Chem.
- EPR Electron Paramagnetic Resonance
- EPR spectra of nitroxide radicals are affected by characteristics of the probe's microenvironment such as mobility, micro viscosity, pH, concentrations of metals and molecular oxygen (Bacic, G., Nitges, M.J., Bennett, H.F., Magin, R.L., and Swartz, H.M., Magn. Resort. Med, 6:445,1988; Dobrucki, J.W., Demsar, T., Walczak, T., Woods, R.K., Bacic. G., and Swartz, H.M., Br. J Cancer, 61 :221, 1990; and Subczinski, W.K., Lukiewicz, S., and Hyde, S., Magn.
- in vivo EPR techniques have further increased the interest in and the need to understand the biological interactions of nitroxides. These techniques usually require adding nitroxides to the system because of the lack of sufficiently high concentrations of naturally occurring paramagnetic molecules in cells or tissues. There is also considerable potential for the use of in vivo EPR techniques to make measurements of classical biophysical parameters such as motion of macromolecules and the state of membranes. In addition, most of the new capabilities of EPR that have been developed in the last few years also could be studied by means of in vivo EPR techniques. These capabilities include the measurement of oxygen concentration (Chan, H.C., Glockner, J., and Swartz, H.M., Biochim. Biophys.
- Ada 1014:141,1989)
- diffusion Demsar, F., Walczak, T.,Morse, P.D., Bacic, G.,Zolnai, Z., and Swartz, H.M., J Magn. Reson., 6:114,X9%%)
- viability Dubruckij.W., Demsar, F., Walczak, T., Woods, R.K., Bacic, G., and Swartz, H.M., Br. J Cancer, 61 :221, 1990
- temperature Chato, J.C., Swartz, H.M., and Robles, J.E., in Boiheat Transfer-Applicahons in Hyperthermia. Emarging Horizons in Instrumentation and Modeling, Romer, R.B., McGrath, J.J., and Bowman, H.F., Eds., American Society of Mechanical Engineers, New York, 1989, 121).
- nitroxide spin probes outside the field of molecular biology.
- the use of nitroxide spin probes is being investigated in such areas as chelating reagents for analytical chemistry, probes for polymer dynamics study, labeling of underground flows for oil production, and quality control of the surface of diamond jewelry, among others.
- the nitroxide radical center is stable, e.g. paramagnetic properties of the spin probes are not time-dependent.
- nitroxide groups are capable of losing their free radical character on interaction (inter- and intramolecular) with a variety of reagents and functional groups (Keana, J.F.W., Chem. Rev., 78, 37, 1978; Volodarsky L.B., ed. Synthetic Chemistry ofNitrroxide Radicals, CRC Press, Boca Raton, FI, 1995).
- This reactivity imposes limitations both on the scope of the reaction that can be employed for nitroxide synthesis and on the possible structures for functional de ⁇ vatives containing a radical center.
- nitroxides which are resistant to in vivo reduction (Keana, J.F.W., Pou, S., and Rosen, G.M., Magn Reson. Med, 5: 525, 1987), nitroxides which specifically localize in a biological system (Swatz, H.M., and Pals, M., Handbook of Biomedicine of Free Radicals and Antioxidants, Vol. 3, edited by J.
- Bioreduction is the most pervasive and bothersome aspect of the use of nitroxides m living biological systems, principally because of the possibility of differential rates of reduction in the va ⁇ ous parts of a complex system and/or the potential biological consequences of the process of reduction (Kocherginsky, N.; Swartz, H.M. Nitroxide Spin Labels: Reactions in Biology and Chemistry. CRC Press, Boca Raton, FI, 1995).
- the hybrid nitroxide-fluorescent probe was introduced by the N. Blough group (Blough N.V.; Simpson, O ., JAm. Chem. Soc, 110: 1915, 1988; Green, S.A.; Simpson, D.J.; Zhou, G.; Ho, P.S.; Though, N.V., JAm. Chem. Soc, 112:7337, 1990; Gerlock, J.L.; Zacmandis, P.J.; Bauer, D.R.; Simpson, D.J.; Though, N.V.; Salmeen, I.T., Free Radical Res. Commun., 10:119, 1990; Kieber, D.; Though N.V., Free Radical Res.
- Blough group performed a theoretical analysis of possible contributions of different quenching mechanisms, including energy transfer (both Forster and Dexter therms), electron transfer, and electron exchange (Green, S.A.; Simpson, D.J.; Zhou, G.; Ho, P.S.; Though, N.Y., JAm. Chem. Soc, 112:7337, 1990). It was concluded that the contributions of energy transfer mechanisms as well as electron transfer are negligible and that the quenching results from a relaxation process induced by electron exchange.
- Rosen group who employed it for detection of the biologically important hydroxyl radical and superoxide in the course of their study of free-radical processes in vivo using confocal fluorescent microscopy (Pou, S.; Huang, Y.I.; Bhan, A.; Bhadfi, V.S.; Hosmane, R.S.; Wu, S.Y.; Cao, G.L; Rosen, G.M. Analyt. Biochem., 212:65,1993; Pou, S.; Wu, S.Y.; Lederer, W.I.; Rosen G.M. Int. Congr. Ser. - Experta Med, 1992,988 (Oxygen Radicals), 20 179.
- hybrid molecules show their potential as research tools.
- variety of hybrid molecules used in the reported research is limited, both in terms of their fluorescent properties and nitroxide triggers.
- the present invention in a general and overall sense, provides for molecular probes having improved paramagnetic properties and high sensitivity.
- These probes may be more particularly described as hybrid probes or dual fluorophore-nitroxide probes comprising a first nitroxide moiety (NR) capable of emitting fluorescence and at least one nitroxide free radical N-O *
- NR nitroxide moiety
- N-O * nitroxide free radical
- the probes of the invention may be further defined as having a structure:
- FI is a fluorescent moiety
- NR is a nitroxide moiety
- N-O * is a nitroxide free radical center.
- the present invention in yet another aspect, provides a method for the synthesis and use of hybrid molecules by combining moieties capable of emitting fluorescence with nitroxide free radical centers.
- These hybrid molecules display a strong interaction between the free radical center and the fluorophore which effectively quenches fluorescence.
- the hybrid molecule On transformation of the nitroxide free radical center to a diamagnetic functional group, the hybrid molecule becomes fluorescent and can easily be detected in extremely low concentrations. Therefore, these hybrid molecules are chemical compounds possessing internal "triggers" which can provide a dramatic molecular response when acted on by specific agents (reductants, free radicals, etc.).
- the use of these unique molecular probes provide utility for use in biological research and medical diagnostics.
- the present invention provides methods to synthesize several series of hybrid molecules. These hybrid molecules are also characterized for their fluorescent properties.
- hybrid compounds in yet another aspect, provides for hybrid compounds.
- these hybrid molecules can be defined as a compound depicted in Scheme 6.
- the hybrid compounds are depicted in Scheme 6 in a general drawing consisting of the fluorophore and the nitroxide moieties, separated by a spacer.
- Fluorophore is the part of the hybrid molecule that makes detection by a spectrometer possible.
- fluorophores for the hybrid molecules of the presently described probes may be further described as having the following characteristics: 1. Compatibility with the presence of a nitroxide moiety. The fluorophore is substantially without strong acidic, oxidative or reductive properties; 2. Comprising functionalities suitable for incorporation into a hybrid molecule without loss of their fluorescent properties;
- fluorescent dyes used as conventional fluorescent probes, including polycyclic aromatic fragment, acridine, coumarine, dansyl, fluorescein, rhodamine, Texas
- the nitroxide part (NR) of the hybrid molecule is responsible for triggering the fluorescence on reduction or reaction with a free radical.
- Reduction of nitroxide free radicals into diamagnetic hydroxylamino derivatives, being the major metabolic pathway in vivo, has been studied by several research groups. It has been reported that the reduction potential of the nitroxide group is determined by its structural features such as size of the cycle (for cyclic nitroxides), the presence of additional heteroatoms in the cycle and substitution (Briggs, S.P., Haug, A.R., and Scheffer, R.P., Plant Physiol, 70:668, 1982; Shchukin, G.
- nitroxide moieties were employed in the synthesis of dual agents. They represented both ends of the nitroxide radicals' oxidation scale. This would permit the preparation of an assortment of hybrid molecules, suitable for studying the oxidation processes, involving both strong and weak reductants.
- Another important structural feature of some nitroxide moieties is its ability to provide the density of unpaired electron (spin density) into the system.
- the extended studies by Nuclear Magnetic Resonance (NNIR) spectroscopy, EPR spectroscopy and quantum-chemical calculations show that the amount of spin density, contributed by nitroxide fragment through spin-polarization mechanism into the molecule, is determined by the structure.
- nitroxide fragments could differ by the orders of magnitude on their spin density donor properties (Grigor'ev, A., and Dikanov, S.A., in Imidazoline Nitroxides, Vol. 1, Synthesis and Properties, Volodarsky, L.B., Ed., CRC Press, Boca Raton, FL, 1988). Since the fluorescence quenching is determined by electron exchange between fluorophore and nitroxide, the ability of nitroxide fragment to donate density of unpaired electron is important for the molecular design of dual probes.
- the spacer is the part of the molecule that connects the fluorophore (FI) and the nitroxide moiety (NR). It should provide maximum interaction between the nitroxide and fluorophore moieties and may optionally contain additional functionalities for addressing a hybrid probe to a specific environment.
- the actual design of the spacer is determined by the desired properties of the dual agents, that in turn reflect the intended application of the agent. Structurally, spacer could consist of the following:
- connection reaction A. Functional group, derived from the connection reaction. This single point short connection spacer is supposed to provide maximum interaction between nitroxide and fluorophore fragment due to its short length. Spacer of this type facilitates electronic exchange by "through space” formation of a FI - NR collision complex.
- C. Longer conjugated spacer capable of ensuring ensure electron exchange between the nitroxide and the fluorophore through the system of conjugate chemical bonds.
- Such spacers may comprise consist of ethyle ic- or heteratom double bonds, or acytylenic bonds, or aromatic (heteroaromatic) disubstituted fragment.
- a spacer of this type works as a "through bond" exchange provider.
- Flexible spacers may comprise a confomationally mobile fragment, providing the interaction between nitroxide and fluorophore upon "through space” formation of the collision complex.
- Such a spacer could contain a methylene group, separating a short functional group spacer (as in A. above), or a longer hydrocarbon chain. Because of a longer space, fluorescence in the dual agents of this type is not fully quenched, but depends upon the imminent distance between the FI and NR moieties.
- A-D A single point short connection, by formation of an ester, an amide or a sulfamide bond.
- hydroxy, or amino derivatives were treated with acylation or sulfonylation reagents.
- the hydroxy, or amino group to be used in this connection could be placed on either the fluorophore or the nitroxide moiety. It could also be a part of a heterocycle, amidine or guanidine system.
- nitroxide acids are more readily available than amines and their active derivatives have already been studied in connection with spin labeling (Hideg, K., and Hankovszky, O.H., in Organic Magnetic Resonance: SpinLabeling VIII; Hopkins, L.J., Reuben, J., Ed., Plenum Press, NY, 1989, Chapter 9) and MRI contrast media synthesis (Volodarsky L.B., ed. Synthetic Chemistry of Nitroxide Radicals, CRC Press, Boca Raton, FI, 1995; Keana, J.F.W., Martin, V.V., Ralston, W.H., U.S.
- nitronyl nitroxides are of particular interest due to their strong delocalization of the spin density of the aromatic substituent in position 2 (Uliman, E.F., Call, L., and Osiecki, J.H., J Org. Chem., 35:3623,1980).
- Such a delocalization should provide strong "through bond" electron exchange between the moieties resulting in strong quenching of fluorescence in the radical 5 form.
- diradical and hybrid molecules The difference between diradical and hybrid molecules is a limited lifetime of the latter in their excited state.
- the characteristic lifetime of conformation is usually longer than that of fluorescence. This means that the excited molecule will undergo photon emission before formation of the collision complex.
- Hybrid probes based on conformation mobility are yet further embodiments of the present invention. They will provide information on changes in the microenvironment that could result in conformational mobility, such as temperature, microviscosity, fluidity, etc. Accommodation of the amide nitrogen, capable of protonation in the bridge, could provide information on the ionic strength and pH of the environment (Martin, V.V., and Keana,
- Nitroxide structural units used as key intermediates (Scheme 9) in the preparations are readily available, stable, and non-toxic compounds.
- nitroxide starting materials used in these preparations are nitroxides an with amino group, namely 4- phenylamino-2,2,2,5-tetrainethyl-3-imidazoline-l-oxyle (5) and 4-amino-2,2,6,6- tetramethylpiperidine-1-oxyl (6).
- Amine 6 is commercially available and was purchased from Aldrich Chemical Co. Most of the preparations listed below are adaptations of the procedures, published elsewhere (Hideg, K; Hankovszky, H.O. In Spin Labeling: Theory and Applications, Vol.8.
- the carboxylic acid 1 was prepared in a four-step reaction sequence from commercial 4-oxo-2,2,6,6-tetramethyl piperidine (triacetoneamine) 6a (Scheme 10). Bromination of the triacetonamine yielded dibromide 7 that was converted to amide 8. Oxidation of this compound with peroxide gave a nitroxide amide 9. Basic hydrolysis of the amide 9 completed the synthesis of the acid 1. Two activated derivatives - N- hydroxysuccinimide ester 10 and mixed anhydride 11 were prepared from the parent carboxylic acid 1. These active derivatives 10, 11 are somewhat less stable in comparison with the parent carboxylic acid 1; however, they can be stored in a freezer for several weeks without decomposition. Scheme 10
- a 17.5 g (0.11 mol) of triacetoneamine 6a was placed into a 500 ml flask equipped with a 100 ml pressure-equalizing dropping funnel and magnetic stirrer. The flask was placed in an ice-water cooling bath and 70 ml of glacial acetic acid was added. At this point, 11.6 ml (0.225 mol) of bromine in 50 ml of glacial acetic acid was added dropwise upon vigorous stirring. After the bromine color disappeared, the stirring was stopped, and reaction mixture was left to stand for a day at room temperature.
- the precipitated crystals of dibromide 7 were collected by filtration, washed on the filter successively with acetic acid (3x5 ml), water (2x5 ml), ether (5x 10 ml) and dried on air to give 29.5 g (68%) of yellow solid, used in the next step without purification.
- Imidazoline carboxylic acid 2 was prepared according to methods known to those of ordinary skill in the art. Readily available hindered amine, 2,2,4,5, 5-pentamethyl-3- imidazoline-3-oxide 12 was used as a starting material. Compound 12 was oxidized to a nitroxide 13, which was brominated with N-bromsuccinimide to give a mixture of mono-14 and dibromo-15 derivatives. Monobromide 14 reacted with t-butyl amine in nucleophilic substitution followed by intramolecular oxidation resulting in the loss of N-oxide oxygen and the formation of imine 16.
- Imine 16 was coverted to amide 17 in a one-pot procedure using hydroxylamine-O-sulphonic acid to give initial nitrile that was subjected to peroxide- catalyzed basic hydrolysis in situ.
- Amide 17 yield the targeted acid 2 upon heating with equimolar amount of sodium hydroxide at 90°C. Free acid 2 was not very stable at room temperatures and was isolated as sodium salt, more convenient for handling.
- a solid 4.6 g (18 mmol) of 4-bromomethyl-2,2,5,5- tetrainethyl-3-imidazoline-3-oxide-l-oxyl 14 was added in portions over 2 hr. at 40°C (bath temperature). After the addition was completed, stirring was continued for another 2 hr. at 40°. The mixture was cooled to room temperature, and 3 ml of water was added. The precipitated solid was filtered, washed with water (3x10 ml), and dried under reduced pressure, yielding 4.09 g (99%) of the imine 16 as an orange solid.
- a solution of potassium hypobromite was prepared by addition of bromine (8.4 ml, 0.16 mol) to the solution of potassium hydroxide (24.6 g, 0.44 mol) in water (60 ml) at -10°C.
- bromine 8.4 ml, 0.16 mol
- potassium hydroxide 24.6 g, 0.44 mol
- a starting l-hydroxy-2,2,4,5,5-pentamethyl-3-imidazolin-3-oxide 18 (6.8 g, 0.04 mol) in water (60 ml) was added dropwise within 10 min at -5°C.
- the mixture was kept for 30 min at -5°C under stirring.
- the precipitated product was filtered off, washed with water, and dried in air, yielding 15 g (92%) of the tribromide 19 as an orange solid.
- Bicyclic carboxylic acid 4 was synthesized via cycloaddition of aldonitrone radical 21 with methyl acrylate followed by the hydrolysis of methyl ester 22 (Scheme 13). Key to this scheme aldonitrone-radical 21 was prepared by oxidation of the l-hydroxy-3-imidazoline-3- oxide 20. Aldonitron 21 is not a stable compound and was used immediately upon isolation (Volodarsky, L.B.; Martin, V.V.; Leluch, T.F. Tetrahedron Lett., 1985, 26(39), 4801).
- amidine-nitroxide 5 was also based on 1,3 dipolar cycloaddition of 2,2,5,5tetramethyl-3-imidazoline-3-oxide-l-oxyl 21, similar to what was used in Example 4. Cycloaddition of aldonitrone-radical 21 to phenylisocyanate gave oxadiazolidine 23. This cycloadduct was transformed to amidine 5 by the reaction with MeONa in aqueous alcohol (Scheme 14).
- the acidic solution was neutralized with solid sodium carbonate to pH 8 and extracted with chloroform (3x15 ml).
- the chloroform extract was dried over magnesium sulfate, filtered, evaporated and the residue was flash chromatographed over silica gel column (2.5x20 cm) using chloroform as eluent, yielding 1.35 g (40%) of the amidine 5 as an orange solid.
- the resulting dual probes 25 a-d have a spacer including methylene group. Their fluorescent properties depend upon the conditions, therefore they could be considered a dual agents with flexible spacers.
- EXAMPLE 9 l-(2'.2'.5'.5'-Tetramethyl-r-oxyl-pyrroline-3'-carbonyl)-aminopyrene (32).
- Method B To a stirred solution of carboxylic acid 1 in 2 ml of 1,2-dimethoxyethane and 0.19 ml (1.4 mmol) of triethylamine was added. 0.11 ml (1.2 mmol) of ethylchloro formate at -5°C under argon.
- the examples 11,12 below represent the synthesis of nitroxide-fluorophore dual probes 42a,b having longer hydrocarbon spacers. These compounds were prepared in similar way by acylation of the terminal amino group of monosubstituted diamines 41a,b.
- the key intermediates 41a,b were synthesized from parent diamines 38a,b in the reaction sequences that include protection, introduction of fluorescent unit (dansyl) followed by deprotection (Scheme 17).
- Dansyl-ethylenediamine 41a
- a 300 ml bench-top high-pressure reactor was charged with 1.17 g (3 mmol) of 1 - dansyl-2-bezyloxycarbonyl-ethylenediamine 40a, 100 ml of dry methanol, and 60 mg Pd/C (catalyst).
- the mixture was hydrogeneted for 2 hr at 30 psi hydrogen pressure, for additional 2 hr at 40 psi, and 68 h at 50 psi.
- the pressure was released, and the catalyst was removed by filtration through Celite-aided filter washed with methanol (3x10 ml).
- the combined filtrate was evaporated and crude conpound 40a was dried under reduced pressure and used without further purification.
- N-dansyl-propane- 1,3 -diamine 41b (0.18 g, 0.6 mmol) in 2 ml of N,N-dimethlyformamide and 0.25 ml (2 mmol) of triethylamine a solid N-hydroxysuccinimide ester 10 (0.18 g, 0.6 mmol) was added portionwise over 10 min.
- the reaction mixture was stirred for 16 hr (control by TLC: eluent - chloroform). The mixture was evaporated to dryness and 10 ml of chloroform was added to the residue.
- the examples 13 and 14 represent the synthesis of dual agents where the exchange between NR and FI moieties happen through the system of conjugated ethyl enic bonds.
- a 3 -imidazoline-3 -oxide- 1 -oxide nitroxide moiety that provides the highest degree of spin density delocalization was employed in these preparations.
- Condensation of l-hydroxy-2,2,4,5,5-pentamethyl-3-imidazoline-3-oxide 18 with 9-antracenyl aldehyde in basic conditions yielded diamagnetic condensation product 63. This compound was oxidized in mild conditions into nitroxide radical 64.
- the compound 64 contains a rigid trans-ethylenic bridge between nitroxide and fluorescent moieties.
- this compound having a nitrone group, was desoxygenated to get dual agent 66 with an imino group instead.
- Heating compound 64 with sodium dithionite resulted in simultaneous loss of N-oxide oxygen atom and reduction of the nitroxide center to give 3- imidazoline derivative 65.
- the regeneration of the radical center was achieved by mild oxidation into targeted compound 66 (Scheme 18).
- Example 15 represents the synthesis of the hybrid fluorophore-nitroxide molecule 44 with a conjugated p-phenylenediamine spacer.
- the key step of this preparation is the acylation of phenylendiamine with acyl chloride 27, prepared in situ from 3- imidazoline-3-oxide carboxylic acid 3. An excess of p-phenylenediamide was employed to avoid possible diacylation.
- Treatment of the intermediate amine 43 with fluorescamine led to the hybrid molecule 44 (Scheme 19).
- Example 16 represents the synthesis of dual probe 45 from nitroxide amidine 5.
- the starting material 5 was treated with dansyl chloride in pyridine in the presence of triethylamine.
- the resulting dual agent has a relatively short sulfamide spacer between the nitroxide moiety and the fluorophore (Scheme 20).
- Examples 17-19 below represent the series of dual molecules were polycyclic aromatic fluorophores are incorporated into a conjugated system of nitronyl nitroxide 53a-d, or imino nitroxide 54a-c compounds.
- Compounds of both nitronyl nitroxide and imino nitroxide series were prepared from commercially available aromatic aldehydes and bis- hydroxylamine 51.
- the starting bis-hydroxylamine 51 was obtained by reduction of bis- nitroso compound, 2,3-dimethyl-2,3-dinitrobutane 50.
- This intermediate in turn was prepared from commercial 2-nitropropane 49 by treatment with bromine.
- R a) 1 -pyryl; b) 9-phenantryl; c) 1-chrysyl;
- the mixture was evaporated to dryness, diluted with 20 ml of chloroform and stirred with 2 g of manganese (IV) oxide for 30 min.
- the inorganic material was filtered off, washed on a filter with chloroform (10 x 10 ml).
- Example 20 represents the synthesis of a double agent 62 with a pyrene fluorophore which is connected to the nitronyl nitroxide moiety through methylene spacer.
- the synthesis of compound 62 was accomplished via nucleophilic substitution of bromine in a bromomethyl group of 2-bromomethyl nitronyl nitroxide 61.
- Preparation of this key intermediate was performed by condensation of bis-hydroxylamine 51 with bromoacetaldehyde followed by the oxidation of intermediate dihydroxyimidazolidine 60 (Scheme 22).
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU31175/99A AU3117599A (en) | 1998-03-28 | 1999-03-26 | Nitroxide free radical dual indicator agents |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US7984898P | 1998-03-28 | 1998-03-28 | |
US60/079,848 | 1998-03-28 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1999050244A1 true WO1999050244A1 (fr) | 1999-10-07 |
WO1999050244A9 WO1999050244A9 (fr) | 1999-12-09 |
Family
ID=22153184
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1999/006688 WO1999050244A1 (fr) | 1998-03-28 | 1999-03-26 | Agents indicateurs doubles comportant un radical libre nitroxyde |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU3117599A (fr) |
WO (1) | WO1999050244A1 (fr) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002008414A1 (fr) * | 2000-06-27 | 2002-01-31 | National Institute Of Advanced Industrial Science And Technology | Nouvelles sondes d'acides nucléiques et procédés d'essai d'acide nucléique par utilisation des mêmes |
JP2009143855A (ja) * | 2007-12-14 | 2009-07-02 | Toyota Central R&D Labs Inc | 有機ラジカル化合物、蓄電デバイス用電極及び蓄電デバイス |
WO2009088801A1 (fr) * | 2007-12-31 | 2009-07-16 | Medical College Of Wisconsin | Composés de piégeage de spin à base de nitrone bifonctionnel et trifonctionnel, et leurs utilisations |
CN110483383A (zh) * | 2018-05-14 | 2019-11-22 | 新发药业有限公司 | 一种吡啶衍生物的制备方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3749645A (en) * | 1971-03-03 | 1973-07-31 | Syva Corp | Free radical assay for redox enzymes |
US5354871A (en) * | 1992-11-27 | 1994-10-11 | National Research Council Of Canada | Pyrroline N-oxide derivatives |
-
1999
- 1999-03-26 WO PCT/US1999/006688 patent/WO1999050244A1/fr active Application Filing
- 1999-03-26 AU AU31175/99A patent/AU3117599A/en not_active Abandoned
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3749645A (en) * | 1971-03-03 | 1973-07-31 | Syva Corp | Free radical assay for redox enzymes |
US5354871A (en) * | 1992-11-27 | 1994-10-11 | National Research Council Of Canada | Pyrroline N-oxide derivatives |
Non-Patent Citations (5)
Title |
---|
BLOUGH N V, SIMPSON D J: "CHEMICALLY MEDIATED FLUORESCENCE YIELD SWITCHING IN NITROXIDE-FLUOROPHORE ADDUCTS: OPTICAL SENSORS OF RADICAL/REDOX REACTIONS", JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, AMERICAN CHEMICAL SOCIETY, US, vol. 110, no. 06, 1 January 1988 (1988-01-01), US, pages 1915 - 1917, XP002921307, ISSN: 0002-7863, DOI: 10.1021/ja00214a041 * |
GERLOCK J L, ET AL.: "FLUORESCENCE DETECTION OF FREE RADICALS BY NITROXIDE SCAVENGING", FREE RADICAL RESEARCH COMMUNICATIONS, HARWOOD ACADEMIC PUBLISHERS, LANGHORNE, PA, US, vol. 10, no. 01/02, 1 January 1990 (1990-01-01), US, pages 119 - 121, XP002921306, ISSN: 8755-0199 * |
GREEN S A, ET AL.: "INTRAMOLECULAR QUENCHING OF EXCITED SINGLET STATES BY STABLE NITROXYL RADICALS", JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, AMERICAN CHEMICAL SOCIETY, US, vol. 112, no. 20, 1 January 1990 (1990-01-01), US, pages 7337 - 7346, XP002921309, ISSN: 0002-7863, DOI: 10.1021/ja00176a038 * |
LOZINSKY E, ET AL.: "DUAL FLUOROPHORE-NITROXIDE PROBES FOR ANALYSIS OF VITAMIN C IN BIOLOGICAL LIQUIDS", JOURNAL OF BIOCHEMICAL AND BIOPHYSICAL METHODS, AMSTERDAM, NL, vol. 38, no. 01, 1 January 1999 (1999-01-01), NL, pages 29 - 42, XP002921305, ISSN: 0165-022X, DOI: 10.1016/S0165-022X(98)00029-3 * |
SOVITJ POU, ET AL.: "A FLUOROPHORE-CONTAINING NITROXIDE AS A PROBE TO DETECT SUPEROXIDE AND HYDROXYL RADICAL GENERATED BY STIMULATED NEUTROPHILS", ANALYTICAL BIOCHEMISTRY., ACADEMIC PRESS INC., NEW YORK., vol. 212, no. 01, 1 January 1993 (1993-01-01), NEW YORK., pages 85 - 90, XP002921308, ISSN: 0003-2697, DOI: 10.1006/abio.1993.1295 * |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002008414A1 (fr) * | 2000-06-27 | 2002-01-31 | National Institute Of Advanced Industrial Science And Technology | Nouvelles sondes d'acides nucléiques et procédés d'essai d'acide nucléique par utilisation des mêmes |
JP2009143855A (ja) * | 2007-12-14 | 2009-07-02 | Toyota Central R&D Labs Inc | 有機ラジカル化合物、蓄電デバイス用電極及び蓄電デバイス |
WO2009088801A1 (fr) * | 2007-12-31 | 2009-07-16 | Medical College Of Wisconsin | Composés de piégeage de spin à base de nitrone bifonctionnel et trifonctionnel, et leurs utilisations |
CN110483383A (zh) * | 2018-05-14 | 2019-11-22 | 新发药业有限公司 | 一种吡啶衍生物的制备方法 |
CN110483383B (zh) * | 2018-05-14 | 2021-04-16 | 新发药业有限公司 | 一种吡啶衍生物的制备方法 |
Also Published As
Publication number | Publication date |
---|---|
AU3117599A (en) | 1999-10-18 |
WO1999050244A9 (fr) | 1999-12-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Ahmed et al. | Recent developments in 1, 2, 3-triazole-based chemosensors | |
Vegesna et al. | pH-activatable near-infrared fluorescent probes for detection of lysosomal pH inside living cells | |
Veale et al. | Synthesis, photophysical, and DNA binding studies of fluorescent Troger’s base derived 4-amino-1, 8-naphthalimide supramolecular clefts | |
Kadjane et al. | Dual‐Frequency Calcium‐Responsive MRI Agents | |
EP1853598B1 (fr) | Composes de sonde chimique devenant fluorescents lors de leur reduction, et leurs methodes d'utilisation | |
Plater et al. | The synthesis and evaluation of o-phenylenediamine derivatives as fluorescent probes for nitric oxide detection | |
Cui et al. | Development of a novel terbium (III) chelate-based luminescent probe for highly sensitive time-resolved luminescence detection of hydroxyl radical | |
CN113637004B (zh) | 一种基于双官能化有机小分子为母体的铝离子检测荧光探针及其制备方法与应用 | |
CA2356344A1 (fr) | Colorants fluorescents destines au criblage de phase solide et de phase solution | |
EP3074403B1 (fr) | Indicateurs de calcium fonctionnalisables émettant dans le rouge fluorescent | |
Martínez-Calvo et al. | 4-Amino-1, 8-naphthalimide based fluorescent photoinduced electron transfer (PET) pH sensors as liposomal cellular imaging agents: The effect of substituent patterns on PET directional quenching | |
CN104478855B (zh) | 3‑氨基‑4‑((e)‑吡啶‑2(1氢)‑烯乙腈基)‑1,8‑萘酰亚胺类衍生物 | |
CN112442056A (zh) | 同时检测次氯酸和过氧化亚硝基阴离子的荧光探针及其合成方法和应用 | |
Vibhute et al. | Synthesis and characterization of pH-sensitive, biotinylated MRI contrast agents and their conjugates with avidin | |
Zatsikha et al. | Functionalized bispyridoneannelated BODIPY–Bright long-wavelength fluorophores | |
WO1999050244A1 (fr) | Agents indicateurs doubles comportant un radical libre nitroxyde | |
Fujii et al. | Solvent-induced multicolour fluorescence of amino-substituted 2, 3-naphthalimides studied by fluorescence and transient absorption measurements | |
CN114656476B (zh) | 溶酶体靶向性罗丹明b酰肼类荧光探针及制备方法和应用 | |
Mamedov et al. | Synthesis and characterization of dinuclear heterometallic lanthanide complexes exhibiting MRI and luminescence response | |
Maffeo et al. | Intramolecular sensitisation of europium (III) luminescence by 8-benzyloxyquinoline in aqueous solution | |
Olsen et al. | pH-Sensitive fluorophores from locked GFP chromophores by a non-alternant analogue of the photochemical meta effect | |
Highfield et al. | Synthesis, hydroxyl radical production and cytotoxicity of analogues of bleomycin | |
Wilkinson et al. | Sensitization of europium (III) luminescence by benzophenone-containing ligands: regioisomers, rearrangements and chelate ring size, and their influence on quantum yields | |
Kálai et al. | Synthesis of paramagnetic BODIPY dyes as new double (spin and fluorescence) sensors | |
Esteves et al. | Synthesis and luminescence properties of analogues of the green fluorescent protein chromophore |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
AK | Designated states |
Kind code of ref document: C2 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: C2 Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
COP | Corrected version of pamphlet |
Free format text: PAGES 1-48, DESCRIPTION, REPLACED BY NEW PAGES 1-47; PAGES 49-53, CLAIMS, REPLACED BY NEW PAGES 48-52; DUE TO LATE TRANSMITTAL BY THE RECEIVING OFFICE |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
NENP | Non-entry into the national phase |
Ref country code: KR |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase |